Mesoblast Financial Data

Company name:Mesoblast LtdStatus:Active
End of fiscal year:June 29 2018ISINAU000000MSB8
Auditor:PricewaterhouseCoopersYear established:2004
Company sector name:HealthcareTrading currency:AUD
Industry name:BiotechnologyPlace of incorporation:Australia (AU)
Industry group nameBiotechnologyDoing business in:Australia (AU)
AddressLevel 38, 55 Collins Street, 3000Tel.:+61 396396036
City/Country:Melbourne, AustraliaFax:+61 396396030
Web address:http://www.mesoblast.com
Company description:Mesoblast is developing adult stem cell therapies based on its proprietary mesenchymal precursor stem cell and culture-expanded mesenchymal stem cell technology platforms. It has nine clinical trial programs across four major areas (cardiovascular, spine disease, immunologic/inflammatory, and cancer) targeting chronic diseases affecting large populations.
Price Price change [%] Bid Offer Open High Low Volume
1.635  -0.065[-3.82%] 1.64 1.65 1.705 1.71 1.63 4,444,847
Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
791.6712949 497.417021 2.30 -0.08 - -22.43 - 1.57 - 5.70

MSB KEY FIGURES (at previous day's close)

Yesterday's Close
1.70
PE Ratio
-22.43
Market Capitalisation
791.67M
Latest Shares Outstanding
497.42M
Earnings pS (EPS)
-0.08
Dividend pS (DPS)
-
Dividend Yield
-
Sales per Employee
214.09k
Effective Tax Rate
-
Foreign Sales
-
Domestic Sales
-
Selling, General & Adm/tive (SG...
126.33%
Research & Devlopment (R&D) as ...
0.00%
Gross Profit Margin
0.00%
EBITDA Margin
-
Pre-Tax Profit Margin
-
Assets Turnover
39.93%
Return on Assets (ROA)
-0.05%
Return on Equity (ROE)
-0.07%
Return on Capital Invested (ROC...
-0.06%
Current Ratio
4.21
Leverage Ratio (Assets/Equity)
1.27%
Interest Cover
-33.62
Total Debt/Equity (Gearing Rati...
0.11%
LT Debt/Total Capital
0.10%
Working Capital pS
1.44
Cash pS
0.08
Book-Value pS
0.23
Tangible Book-Value pS
0.01
Cash Flow pS
-0.16
Free Cash Flow pS
-0.16
Spread
0.01
Gross gearing
0.00%
Net Debt
-37.76M

MSB Balance Sheet Chart (June 29 2018)

:liab eq:assets
Period High Low
1 Week1.771.63
1 Month2.071.57
3 Months2.251.57
6 Months2.521.57
1 Year5.701.57
3 Years5.701.015
5 Years5.701.015

Share price performance previous 3 years

Share price performance intraday

Period Open Open Avg. VWAP Min Vol Max Vol Avg. Daily Vol Change %
1 Week1.7551.701.701,200,5504,452,4952,139,001-0.12-6.84%
1 Month1.8851.79931.731,200,55020,854,5235,043,815-0.25-13.26%
3 Months2.211.92581.85866,67420,854,5233,167,414-0.575-26.02%
6 Months2.462.00381.94866,67420,854,5232,924,434-0.825-33.54%
1 Year4.872.57572.90494,97766,787,9044,989,870-3.24-66.43%
3 Years1.722.35322.9972,12266,787,9044,113,368-0.085-4.94%
5 Years1.2152.05522.7872,12266,787,9042,849,8530.4234.57%

MSB Growth Ratios (June 29 2018)

1 year 3 years 5 years 10 years
Diluted EPS growth
-
-
-
-
Diluted continuous EPS growth
-
-
-
-
Dividend growth
-
-
-
-
Equity per share growth
-0.05
-0.14
-0.11
0.18
Revenue growth
6.19
-0.10
-0.10
0.34
Operating income growth
-
-
-
-
Net income growth
-
-
-
-
Net income cont growth
-
-
-
-
CFO growth
-
-
-
-
FCF growth
-
-
-
-
Operating revenue growth
6.19
-0.10
-0.10
0.34

MSB Income Statement June 29 2018 (USD)

Total Revenue
17.341
Operating Revenue
17.341
Operating Expenses
92.191
Selling,General and Administr...
21.907
General and Administrative Ex...
21.907
OtherGandA
21.907
Research and Development
65.927
Taxes Other Than Income Taxes
-1.151
Other Operating Expenses
5.508
Operating Income
-74.85
Interest Income/Expense,Net-N...
-1.829
Interest Expense-Non Operatin...
1.829
Other Income/Expense,Net
10.702
Gain on Sale of Securities
0.161
Special Income/Charges
10.541
Restructuring and Merger&Acqu...
-10.541
Impairment of Capital Assets
0.00
Pretax Income
-65.977
Provision for Income Tax
-30.687
Net Income Available to Commo...
-35.29
Net Income
-35.29
Net Income Including Noncontr...
-35.29
Net Income from Continuing Op...
-35.29
DilutedNIAvailtoComStockholde...
-35.29
Basic EPS
-0.08
Basic EPS from Continuing Ope...
-0.08
Basic EPS from Discontinued O...
0.00
Diluted EPS
-0.08
Diluted EPS from Continuing O...
-0.08
Diluted EPS from Discontinued...
0.00
Basic Weighted Average Shares...
465.688997
Diluted Weighted Average Shar...
465.688997
Total Expenses
92.191
Net Income from Continuing an...
-35.29
Normalized Income
-42.7814
Basic EPS,Continuing and Disc...
-0.08
Diluted EPS,Continuing and Di...
-0.08
Interest Expense
1.829
Net Interest Income
-1.829
Earning Before Interest and T...
-64.148
Earning Before Interest Tax D...
-61.498
Depreciation,Reconciled
2.65
Net Income from Continuing Op...
-35.29
TotalUnusualItemsExcludingGoo...
10.702
TotalUnusualItems
10.702
Normalized Basic EPS
-0.09
Normalized Diluted EPS
-0.09
NormalizedEBITDA
-72.2
Tax rate for calculations
0.30
TotalRevenueAsReported
17.341

MSB Efficency Ratios (June 29 2018)

Days in sales
74.76
Days in inventory
-
Days in payment
-
Cash conversion cycle
-
Receivable turnover
4.88
Inventory turnover
-
Payable turnover
-
Fixed assets turnover
11.97
Assets turnover
0.03
ROE
-0.07
ROA
-0.05
ROIC
-0.06
FCF sales ratio
-
FCF net income ratio
-
Capital expenditure sales ratio
0.01

MSB Financial Health Ratios (June 29 2018)

Current ratio
4.21
Quick ratio
3.66
Debt total capital ratio
0.10
Debt equity ratio
0.11
Financial leverage
1.27
Total debt to equity
0.11

MSB Avearge Growth Ratios Over 5 Years (June 29 2018)

Growth ann capital spending
-0.41
Growth ann gross profit
-
Avg gross margin
-
Avg post tax margin
-8.42
Avg pre tax marginr
-10.30
Avg net profit
-8.42
Avg ret commonr
-0.11
Avg ret assets
-0.08
Avg ret invested capital
-0.11

MSB Profitability Ratios (June 29 2018)

Gross margin
-
Operating margin
-4.32
EBT margin
-3.80
Tax rate
-
Net margin
-2.04
Sales per employee
214,086.42
EBIT margin
-3.70
EBITDA margin
-3.55
Normalized net profit margin
-2.47
Interest coverage
-35.07
Inc per employee tot ops
-

MSB Valuation Ratios (June 28 2018)

Sales per share
0.05
Growth ann sales per share 5 ye...
-0.29
Book value per share
1.58
CF per share
-0.23
Price to EPS
-
Ratio PE 5 year high
-
Ratio PE 5 year low
-
Price to book
0.94
Price to sales
30.49
Price to cash flow
-
Price to free cash flow
-
Div rate
-
Dividend yield
-
Div payout tot ops
-
Div payout 5 year
-
Payout ratio
0.00
Sustainable growth rate
-0.08
Cash return
-0.16

MSB Balance Sheet June 29 2018 (USD)

Total Assets
692.443
Current Assets
101.071
Cash,Cash Equivalents,and Sho...
37.763
Cash and Cash Equivalents
37.763
Cash
37.221
Cash Equivalents
0.542
Receivables
50.116
Accounts Receivable
6.63
Accrued Interest Receivable
0.011
Taxes Receivable
3.829
Other Receivables
39.646
Prepaid Assets and Others
13.192
Total Non-Current Assets
591.372
Net Property,Plant,and Equipm...
1.084
Gross Property,Plant,and Equi...
8.6
Machinery,Furniture/Equipment
8.6
Accumulated Depreciation
-7.516
Goodwill and Other Intangible...
584.606
Goodwill
134.453
Other Intangible Assets
450.153
Investments and Advances
2.321
Investment in Financial Asset...
2.321
Available-for-Sale Securities
2.321
Accounts Receivable,Non-Curre...
1.473
Other Non-Current Assets
1.888
Total Liabilities
146.435
Current Liabilities
24.003
Payables and Accrued Expenses
18.921
Payables
18.921
Accounts Payable
18.921
Provisions,Current
5.082
Total Non-Current Liabilities
122.432
Provisions,Long Term
42.956
Long Term Debt and Capital Le...
59.397
Long Term Debt
59.397
Deferred Liabilities, Non cur...
20.079
Deferred Taxes,Non-Current Li...
20.079
Total Equity
546.008
Stockholder's Equity
546.008
Capital Stock
0.00
Common Stock
0.00
Additional Paid in Capital
889.481
Retained Earnings
-380.192
Accumulated Gains/ Losses Not...
36.719
Total Capitalization
605.405
Common Stock Equity
546.008
Net Tangible Assets
-38.598
Working Capital
77.068
Invested Capital
605.405
Tangible Book Value
-38.598
Total Debt
59.397
NetDebt
21.634
Ordinary Shares Number
479.139654
Treasury Shares Number
3.5
TotalLiabilitiesAsReported
146.435
TotalEquityAsReported
546.008

MSB Cash Flow June 29 2018 (USD)

Cash Flow from Operating Acti...
-75.012
Cash Flow from Continuing Ope...
-75.012
Net Income from Continuing Op...
-35.29
Operating Gains/Losses
-0.16
Net Foreign Currency Exchange...
-0.16
Depreciation,Amortization and...
2.65
Depreciation and Amortization
2.65
Deferred Taxes
-30.664
Deferred Income Tax
-30.664
Asset Impairment Charge
0.00
Stock-Based Compensation
6.199
Other Non-Cash Items
-8.816
Changes in Working Capital
-8.931
Change in Receivables
-7.9
Changes in Account Receivable...
-6.093
Change in Prepaid Assets
1.503
Change in Payables and Accrue...
-4.464
Change in Other Working Capit...
1.93
Cash Flow from Investing Acti...
-1.153
Cash Flow from Continuing Inv...
-1.153
Purchase/Sale of Property,Pla...
-0.201
Purchase of Property,Plant an...
-0.201
Purchase/Sale of Intangibles,...
0.00
Purchase of Intangibles
0.00
Purchase/Sale of Business,Net
-0.952
Purchase/Acquisition of Busin...
-0.952
Purchase/Sale of Investments,...
0.00
Purchase of Investments
0.00
Cash Flow from Financing Acti...
68.613
Cash Flow from Continuing Fin...
68.613
Issuance/Payments of Debt,Net
31.704
Issuance/Payments of Long Ter...
31.704
Proceeds or Issuance of Long ...
31.704
Issuance/Payments of Common S...
40.566
Proceeds or Issuance of Commo...
40.566
Other Financing Changes, Net
-3.657
Cash and Cash Equivalents,End...
37.763
Change in Cash
-7.552
Effect of Exchange Rate Chang...
-0.446
Cash and Cash Equivalents,Beg...
45.761
Capital Expenditure
-0.201
Issuance of Capital Stock
40.566
Issuance of Debt
31.704
Free Cash Flow
-75.213
ChangeinCashSupplementalAsRep...
-7.552
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210919 14:04:24